Improving clinical trials in underserved states through better communication and resources
Official title: The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
Funded at West Virginia University · NIH-11084098 · Data updated 2026-11-12
This study is working to increase the number of clinical trials in certain states that don't have many right now, making it easier for researchers and hospitals to connect and help more people get involved in important health studies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | West Virginia University NIH-funded |
| Lab location | 1 site (Morgantown, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $1,345,186 |
| NIH project number | 3U24GM150446-02S1 |
| Project ID | NIH-11084098 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include patients residing in IDeA states who are interested in participating in clinical trials.
✕Less likely to help
Patients living outside of IDeA states may not receive direct benefits from this research.
What this research studies
This research aims to enhance the number of clinical trials and observational studies conducted in Institutional Development Award (IDeA) states, which currently host less than 10% of NIH-funded studies. The project will establish the IDeA State Consortium for Clinical Research Resource Center (ISCORE-RC) to improve communication between trial sponsors and IDeA institutions, showcasing their capabilities. It will also develop a Clinical Research Coordinator (CRC) Development Program to address workforce challenges. By leveraging platforms like TriNetX, the project seeks to connect clinical trial sponsors with IDeA state institutions effectively.
Why it matters
Potential benefit: If successful, this research could significantly increase access to clinical trials for patients in IDeA states, leading to improved healthcare outcomes.
How similar studies have gone: While there have been efforts to improve clinical trial access in underserved areas, this approach is particularly novel in its focus on IDeA states and the establishment of a dedicated consortium.
Where this research is happening
-
West Virginia University
Morgantown, United States Active
Researchers
- Principal investigator: Hodder, Sally Lynn — West Virginia University
- Study coordinator: Hodder, Sally Lynn
Related research
Other NIH-funded projects on the same topics.
-
West Virginia Rural Roots to Research: bringing clinical trials to Appalachian communities
A wide-network program in rural West Virginia is building patient-friendly clinical trials so people in Appalachia have better access to new cancer treatments and care.
-
CD38-Driven Changes in Brain Tumor Metabolism and Immunity in Glioblastoma
A patient-facing look at how scientists plan to study how glioblastoma grows by changing its metabolism and dampening the immune response, with potential targets to help treatment in the future.
-
Combinatorial targeting for high-risk B-cell ALL treatment
A research effort at West Virginia University is exploring a combination therapy for adult B-cell acute lymphoblastic leukemia using targeted gene silencing and a small-molecule compound to improve treatment in patients.
-
New mRNA vaccines and antibody therapies to prevent and treat pertussis
A program to create and test new mRNA vaccines and antibody therapies to stop whooping cough from spreading and causing illness in people of all ages.
-
Targeting teens’ social media use and real-time chats to improve well-being
A teen-focused program tests whether reducing social media, boosting real-time conversations, or journaling can improve well-being in 10th graders.
-
Molecular Regulators of Cone Opsin Trafficking
A study to understand how light-sensitive cone proteins are moved to the part of the eye that detects light, with the goal of helping people with certain inherited eye diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.